Al-Razi Medical Co.
9572.SRSAUHealthcare● Active
$29.22
+$0.90(+3.18%)
Market Cap$44414400
P/E Ratio—
52W High$45.7
52W Low$25.1
Al-Razi Medical Co. (9572.SR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 9572.SR · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $74.38M | $61.35M | $61.33M | $52.39M | $45.19M |
| Cost of Revenue | $55.09M | $44.76M | $44.03M | $38.84M | $33.98M |
| Gross Profit | $19.30M | $16.59M | $14.07M | $13.55M | $11.21M |
| Gross Margin %(computed) | 25.94% | 27.04% | 22.95% | 25.87% | 24.81% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $1.34M | $1.23M | $1.26M | $1.13M | $1.76M |
| Total Operating Expenses | $17.72M | $16.15M | $12.26M | $10.66M | $8.56M |
| Operating Income | $1.57M | $0.43M | $1.81M | $2.89M | $2.65M |
| Operating Margin %(computed) | 2.12% | 0.71% | 2.96% | 5.52% | 5.85% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.90M | $0.48M | $0.30M | $0.60M |
| Income Before Tax | $1.07M | $0.53M | $1.09M | $2.43M | $2.53M |
| Income Tax Expense | $0.25M | $0.35M | $0.40M | $0.41M | $0.37M |
| Net Income | $0.82M | $0.18M | $0.69M | $2.01M | $2.16M |
| Net Margin %(computed) | 1.10% | 0.29% | 1.12% | 3.84% | 4.79% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.54 | $0.12 | $0.45 | $1.33 | $1.42 |
| Wtd Avg Shares | 1.52M | 1.47M | 1.52M | 1.52M | 1.52M |
| EBITDA | $1.57M | $0.43M | $5.07M | $5.72M | $5.12M |
| EBITDA Margin %(computed) | 2.12% | 0.71% | 8.27% | 10.92% | 11.34% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · M
Explore more Al-Razi Medical Co. data
About Al-Razi Medical Co. (9572.SR) Income Statement
Al-Razi Medical Co. (9572.SR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, 9572.SR reported revenue of $0.07B, gross profit of $0.02B (gross margin 25.94%), and net income of $0.00B — a net profit margin of 1.10%.
Frequently asked questions
9572.SR · 4 questionsAl-Razi Medical Co. (9572.SR) reported revenue of $0.07B for 2025, up 21.2% year-over-year.
9572.SR revenue9572.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15